VI
ABBV icon

Vestcor Inc’s AbbVie ABBV Stock Holding History

Vestcor Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1M Sell
71,946
-1,695
-2% -$365K 0.45% 49
2026
Q1 		$16M Sell
73,641
-15,029
-17% -$3.33M 0.44% 53
2025
Q4 		$20.3M Sell
88,670
-2,216
-2% -$505K 0.58% 38
2025
Q3 		$21M Sell
90,886
-1,776
-2% -$362K 0.63% 30
2025
Q2 		$17.2M Buy
92,662
+4,812
+5% +$894K 0.52% 42
2025
Q1 		$18.4M Buy
87,850
+9,539
+12% +$1.85M 0.62% 34
2024
Q4 		$13.9M Sell
78,311
-2,733
-3% -$502K 0.46% 51
2024
Q3 		$16M Hold
81,044
– – 0.5% 43
2024
Q2 		$13.9M Buy
81,044
+1,179
+1% +$195K 0.47% 47
2024
Q1 		$14.5M Sell
79,865
-4,568
-5% -$787K 0.5% 42
2023
Q4 		$13.1M Buy
84,433
+6,624
+9% +$966K 0.44% 48
2023
Q3 		$11.6M Buy
77,809
+19,339
+33% +$2.84M 0.42% 50
2023
Q2 		$7.88M Buy
58,470
+10,326
+21% +$1.51M 0.29% 82
2023
Q1 		$7.67M Buy
48,144
+3,221
+7% +$492K 0.28% 79
2022
Q4 		$7.26M Buy
44,923
+312
+0.7% +$47.8K 0.27% 87
2022
Q3 		$5.99M Buy
44,611
+469
+1% +$67.3K 0.23% 102
2022
Q2 		$6.76M Buy
44,142
+16,177
+58% +$2.47M 0.25% 92
2022
Q1 		$4.53M Buy
27,965
+337
+1% +$49K 0.16% 151
2021
Q4 		$3.74M Sell
27,628
-4,876
-15% -$576K 0.13% 175
2021
Q3 		$3.51M Sell
32,504
-3,596
-10% -$411K 0.13% 200
2021
Q2 		$4.07M Sell
36,100
-59,499
-62% -$6.7M 0.14% 180
2021
Q1 		$10.3M Buy
95,599
+9,467
+11% +$1.01M 0.39% 72
2020
Q4 		$9.23M Buy
86,132
+16,342
+23% +$1.57M 0.38% 75
2020
Q3 		$6.11M Buy
69,790
+25,596
+58% +$2.41M 0.28% 105
2020
Q2 		$4.34M Buy
44,194
+9,085
+26% +$800K 0.22% 131
2020
Q1 		$2.67M Buy
35,109
+5,636
+19% +$480K 0.15% 170
2019
Q4 		$2.61M Buy
+29,473
New +$2.45M 0.12% 216

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vestcor Inc's ABBV Position: Q2 2026 in Review

Vestcor Inc reduced its AbbVie (ABBV) stake by 2.3% in Q2 2026, selling an estimated $365K and leaving 71,946 shares worth $18.1M. The position accounts for 0.45% of the portfolio, ranked #49.

Vestcor Inc first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $21M in Q3 2025. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vestcor Inc held 71,946 shares of AbbVie worth $18.1M as of Q2 2026.
  • Vestcor Inc sold 1,695 AbbVie shares in Q2 2026, an estimated $365K.
  • AbbVie made up 0.45% of Vestcor Inc's portfolio in Q2 2026, its #49 holding.
  • Vestcor Inc first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's AbbVie position peaked at $21M in Q3 2025.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.